verapamil has been researched along with Atypical Mycobacterial Infection, Disseminated in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurst-Hess, KR | 1 |
| Phelps, GA | 1 |
| Wilt, LA | 1 |
| Lee, RE | 1 |
| Ghosh, P | 1 |
| Viljoen, A | 1 |
| Raynaud, C | 1 |
| Johansen, MD | 1 |
| Roquet-Banères, F | 1 |
| Herrmann, JL | 1 |
| Daher, W | 1 |
| Kremer, L | 1 |
| Adams, KN | 1 |
| Takaki, K | 1 |
| Connolly, LE | 1 |
| Wiedenhoft, H | 1 |
| Winglee, K | 1 |
| Humbert, O | 1 |
| Edelstein, PH | 1 |
| Cosma, CL | 1 |
| Ramakrishnan, L | 1 |
| La Rosa, V | 1 |
| Poce, G | 1 |
| Canseco, JO | 1 |
| Buroni, S | 1 |
| Pasca, MR | 1 |
| Biava, M | 1 |
| Raju, RM | 1 |
| Porretta, GC | 1 |
| Alfonso, S | 1 |
| Battilocchio, C | 1 |
| Javid, B | 1 |
| Sorrentino, F | 1 |
| Ioerger, TR | 1 |
| Sacchettini, JC | 1 |
| Manetti, F | 1 |
| Botta, M | 1 |
| De Logu, A | 1 |
| Rubin, EJ | 1 |
| De Rossi, E | 1 |
4 other studies available for verapamil and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Mab2780c, a TetV-like efflux pump, confers high-level spectinomycin resistance in mycobacterium abscessus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Microbial Sensitivity Tests; Molecular Docking Simulation; M | 2023 |
Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Cell Line; Diarylquinolines; Drug | 2019 |
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Disease Models, Animal; Drug Tolerance; Granulom | 2011 |
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
Topics: Animals; Antitubercular Agents; Carbon Radioisotopes; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cat | 2012 |